Skip to main content

News

Metformin Reduces Osteoarthritis Risk in NIDDM Patients

EurekAlert!

Osteoarthritis is a common chronic condition that usually causes joint pain and can be severe enough to require knee and hip replacements.

Best of 2022: Approach to ILD in Myositis Syndromes

Mehta et al have published a full read review of managing interstitial lung disease (ILD) in patients with inflammatory myopathies, a heterogeneous group of syndromes connected by ILD and and increased morbidity and mortality risk.

Fever, FROST, & Pericarditis (12.16.2022)

Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK".

COVID-19 Vaccine Responses in Rheumatic Disease Patients

Nature Reviews Rheumatology features a review of three notable papers that address the impact of SARS-CoV-2 vaccination on people with inflammatory rheumatic disease. 

JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD

The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected. This review examines the available clinical literature on the potential benefits and outcomes of JAK inhibitor use in SSc=ILD.

ACR New Guidelines on Integrative Approach to RA

ACR

The American College of Rheumatology (ACR) released a summary of its new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis.

CXCL5 Therapy in Lupus?

EurekAlert!
 A new study has shown that restoring the balance of a protein in blood may be a promising treatment option for systemic lupus erythematosus.

Marginal Benefit with Diet and Exercise in Obese Knee Osteoarthritis Patients

The easiest intervention for knee osteoarthritis (diet and exercise) is also the most difficult for many patients; but do these work? A new study of a weight loss and exercise program in community settings shows only marginal benefits. 

Efgartigimod Treatment in Chronic Primary ITP

EurekAlert!

Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results repor

Substandard Therapy in Rheumatoid Arthritis

Medpage Today

Clinicians could improve outcomes in their patients with rheumatoid arthritis (RA) by paying attention to certain markers of care quality, such as early referral to certified rheumatologists and prescribing standard drugs for RA, new research suggested.

2022 ACR/EULAR Giant Cell Arteritis Classification Criteria

Giant cell arteritis (GCA) has historically been a clinical diagnosis (visual loss, headache, jaw pain, scalp tenderness, etc) supported by labs and histopathology.

Inflammatory Arthritis and Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) (also called acne inversa), is a chronic inflammatory skin disorder affecting apocrine gland-bearing skin in the axillae, groin, and under the breasts and is characterised by

×